The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infectious Bursal Disease Vaccine Market Research Report 2025
Synopsis
Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
The global Infectious Bursal Disease Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Infectious Bursal Disease Vaccine include Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd. and Ruipu Biopharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Bursal Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Bursal Disease Vaccine.
Report Scope
The Infectious Bursal Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Bursal Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Bursal Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Segment by Type
Live
Inactivated
Segment by Application
Veterinary Pharmacy
Online Sale
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Infectious Bursal Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Infectious Bursal Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
The global Infectious Bursal Disease Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infectious Bursal Disease Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Infectious Bursal Disease Vaccine include Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd. and Ruipu Biopharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Bursal Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Bursal Disease Vaccine.
Report Scope
The Infectious Bursal Disease Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Bursal Disease Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Bursal Disease Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
Segment by Type
Live
Inactivated
Segment by Application
Veterinary Pharmacy
Online Sale
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Infectious Bursal Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Infectious Bursal Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Infectious Bursal Disease Vaccine Market Overview
1.1 Product Overview and Scope of Infectious Bursal Disease Vaccine
1.2 Infectious Bursal Disease Vaccine Segment by Type
1.2.1 Global Infectious Bursal Disease Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Live
1.2.3 Inactivated
1.3 Infectious Bursal Disease Vaccine Segment by Application
1.3.1 Global Infectious Bursal Disease Vaccine Market Value by Application: (2024-2030)
1.3.2 Veterinary Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Global Infectious Bursal Disease Vaccine Market Size Estimates and Forecasts
1.4.1 Global Infectious Bursal Disease Vaccine Revenue 2019-2030
1.4.2 Global Infectious Bursal Disease Vaccine Sales 2019-2030
1.4.3 Global Infectious Bursal Disease Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Infectious Bursal Disease Vaccine Market Competition by Manufacturers
2.1 Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Infectious Bursal Disease Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Infectious Bursal Disease Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Infectious Bursal Disease Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Infectious Bursal Disease Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Infectious Bursal Disease Vaccine, Product Type & Application
2.7 Infectious Bursal Disease Vaccine Market Competitive Situation and Trends
2.7.1 Infectious Bursal Disease Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Infectious Bursal Disease Vaccine Players Market Share by Revenue
2.7.3 Global Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Infectious Bursal Disease Vaccine Retrospective Market Scenario by Region
3.1 Global Infectious Bursal Disease Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Infectious Bursal Disease Vaccine Global Infectious Bursal Disease Vaccine Sales by Region: 2019-2030
3.2.1 Global Infectious Bursal Disease Vaccine Sales by Region: 2019-2024
3.2.2 Global Infectious Bursal Disease Vaccine Sales by Region: 2025-2030
3.3 Global Infectious Bursal Disease Vaccine Global Infectious Bursal Disease Vaccine Revenue by Region: 2019-2030
3.3.1 Global Infectious Bursal Disease Vaccine Revenue by Region: 2019-2024
3.3.2 Global Infectious Bursal Disease Vaccine Revenue by Region: 2025-2030
3.4 North America Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.4.1 North America Infectious Bursal Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Infectious Bursal Disease Vaccine Sales by Country (2019-2030)
3.4.3 North America Infectious Bursal Disease Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.5.1 Europe Infectious Bursal Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Infectious Bursal Disease Vaccine Sales by Country (2019-2030)
3.5.3 Europe Infectious Bursal Disease Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Infectious Bursal Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Infectious Bursal Disease Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Infectious Bursal Disease Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.7.1 Latin America Infectious Bursal Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Infectious Bursal Disease Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Infectious Bursal Disease Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Infectious Bursal Disease Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Infectious Bursal Disease Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Infectious Bursal Disease Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Infectious Bursal Disease Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Infectious Bursal Disease Vaccine Sales by Type (2019-2030)
4.1.1 Global Infectious Bursal Disease Vaccine Sales by Type (2019-2024)
4.1.2 Global Infectious Bursal Disease Vaccine Sales by Type (2025-2030)
4.1.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Infectious Bursal Disease Vaccine Revenue by Type (2019-2030)
4.2.1 Global Infectious Bursal Disease Vaccine Revenue by Type (2019-2024)
4.2.2 Global Infectious Bursal Disease Vaccine Revenue by Type (2025-2030)
4.2.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Infectious Bursal Disease Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Infectious Bursal Disease Vaccine Sales by Application (2019-2030)
5.1.1 Global Infectious Bursal Disease Vaccine Sales by Application (2019-2024)
5.1.2 Global Infectious Bursal Disease Vaccine Sales by Application (2025-2030)
5.1.3 Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Infectious Bursal Disease Vaccine Revenue by Application (2019-2030)
5.2.1 Global Infectious Bursal Disease Vaccine Revenue by Application (2019-2024)
5.2.2 Global Infectious Bursal Disease Vaccine Revenue by Application (2025-2030)
5.2.3 Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Infectious Bursal Disease Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Infectious Bursal Disease Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Infectious Bursal Disease Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Elanco
6.3.1 Elanco Corporation Information
6.3.2 Elanco Description and Business Overview
6.3.3 Elanco Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Elanco Infectious Bursal Disease Vaccine Product Portfolio
6.3.5 Elanco Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Corporation Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ceva Infectious Bursal Disease Vaccine Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 Qingdao Yibang Biological Engineering Co., Ltd.
6.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Corporation Information
6.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Description and Business Overview
6.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
6.7 Shandong Lvdu Biological Technology Co., Ltd.
6.6.1 Shandong Lvdu Biological Technology Co., Ltd. Corporation Information
6.6.2 Shandong Lvdu Biological Technology Co., Ltd. Description and Business Overview
6.6.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.7.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
6.8 Plyco Bioengineering Co., Ltd.
6.8.1 Plyco Bioengineering Co., Ltd. Corporation Information
6.8.2 Plyco Bioengineering Co., Ltd. Description and Business Overview
6.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.8.5 Plyco Bioengineering Co., Ltd. Recent Developments/Updates
6.9 Ruipu Biopharmaceutical Co., Ltd.
6.9.1 Ruipu Biopharmaceutical Co., Ltd. Corporation Information
6.9.2 Ruipu Biopharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.9.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
6.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporation Information
6.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Business Overview
6.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Portfolio
6.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infectious Bursal Disease Vaccine Industry Chain Analysis
7.2 Infectious Bursal Disease Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infectious Bursal Disease Vaccine Production Mode & Process
7.4 Infectious Bursal Disease Vaccine Sales and Marketing
7.4.1 Infectious Bursal Disease Vaccine Sales Channels
7.4.2 Infectious Bursal Disease Vaccine Distributors
7.5 Infectious Bursal Disease Vaccine Customers
8 Infectious Bursal Disease Vaccine Market Dynamics
8.1 Infectious Bursal Disease Vaccine Industry Trends
8.2 Infectious Bursal Disease Vaccine Market Drivers
8.3 Infectious Bursal Disease Vaccine Market Challenges
8.4 Infectious Bursal Disease Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Infectious Bursal Disease Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Infectious Bursal Disease Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Infectious Bursal Disease Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Infectious Bursal Disease Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Infectious Bursal Disease Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Infectious Bursal Disease Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Infectious Bursal Disease Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Infectious Bursal Disease Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Infectious Bursal Disease Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Infectious Bursal Disease Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Infectious Bursal Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Bursal Disease Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Infectious Bursal Disease Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Infectious Bursal Disease Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Infectious Bursal Disease Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Infectious Bursal Disease Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Infectious Bursal Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Infectious Bursal Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Infectious Bursal Disease Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Infectious Bursal Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Infectious Bursal Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Infectious Bursal Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Infectious Bursal Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Infectious Bursal Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Infectious Bursal Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Infectious Bursal Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Infectious Bursal Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Infectious Bursal Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Infectious Bursal Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Infectious Bursal Disease Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Infectious Bursal Disease Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Infectious Bursal Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Infectious Bursal Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Infectious Bursal Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Infectious Bursal Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Infectious Bursal Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Infectious Bursal Disease Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Infectious Bursal Disease Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Infectious Bursal Disease Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Infectious Bursal Disease Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Infectious Bursal Disease Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Infectious Bursal Disease Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Infectious Bursal Disease Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Infectious Bursal Disease Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Infectious Bursal Disease Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Infectious Bursal Disease Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Infectious Bursal Disease Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Zoetis Infectious Bursal Disease Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck Infectious Bursal Disease Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. Elanco Corporation Information
Table 81. Elanco Description and Business Overview
Table 82. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Elanco Infectious Bursal Disease Vaccine Product
Table 84. Elanco Recent Developments/Updates
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Ceva Corporation Information
Table 91. Ceva Description and Business Overview
Table 92. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Ceva Infectious Bursal Disease Vaccine Product
Table 94. Ceva Recent Developments/Updates
Table 95. Qingdao Yibang Biological Engineering Co., Ltd. Corporation Information
Table 96. Qingdao Yibang Biological Engineering Co., Ltd. Description and Business Overview
Table 97. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 99. Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
Table 100. Shandong Lvdu Biological Technology Co., Ltd. Corporation Information
Table 101. Shandong Lvdu Biological Technology Co., Ltd. Description and Business Overview
Table 102. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 104. Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
Table 105. Plyco Bioengineering Co., Ltd. Corporation Information
Table 106. Plyco Bioengineering Co., Ltd. Description and Business Overview
Table 107. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 109. Plyco Bioengineering Co., Ltd. Recent Developments/Updates
Table 110. Ruipu Biopharmaceutical Co., Ltd. Corporation Information
Table 111. Ruipu Biopharmaceutical Co., Ltd. Description and Business Overview
Table 112. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 114. Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporation Information
Table 116. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Description and Business Overview
Table 117. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product
Table 119. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Infectious Bursal Disease Vaccine Distributors List
Table 123. Infectious Bursal Disease Vaccine Customers List
Table 124. Infectious Bursal Disease Vaccine Market Trends
Table 125. Infectious Bursal Disease Vaccine Market Drivers
Table 126. Infectious Bursal Disease Vaccine Market Challenges
Table 127. Infectious Bursal Disease Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Infectious Bursal Disease Vaccine
Figure 2. Global Infectious Bursal Disease Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Infectious Bursal Disease Vaccine Market Share by Type in 2023 & 2030
Figure 4. Live Product Picture
Figure 5. Inactivated Product Picture
Figure 6. Global Infectious Bursal Disease Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Infectious Bursal Disease Vaccine Market Share by Application in 2023 & 2030
Figure 8. Veterinary Pharmacy
Figure 9. Online Sale
Figure 10. Others
Figure 11. Global Infectious Bursal Disease Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Infectious Bursal Disease Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Infectious Bursal Disease Vaccine Sales (2019-2030) & (K Units)
Figure 14. Global Infectious Bursal Disease Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 15. Infectious Bursal Disease Vaccine Report Years Considered
Figure 16. Infectious Bursal Disease Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Infectious Bursal Disease Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Infectious Bursal Disease Vaccine Players: Market Share by Revenue in 2023
Figure 19. Infectious Bursal Disease Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Infectious Bursal Disease Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Infectious Bursal Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Infectious Bursal Disease Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. United States Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Infectious Bursal Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Infectious Bursal Disease Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Infectious Bursal Disease Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Infectious Bursal Disease Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Infectious Bursal Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 44. Latin America Infectious Bursal Disease Vaccine Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Infectious Bursal Disease Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Infectious Bursal Disease Vaccine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Infectious Bursal Disease Vaccine by Type (2019-2030)
Figure 56. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Infectious Bursal Disease Vaccine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Infectious Bursal Disease Vaccine by Application (2019-2030)
Figure 59. Global Infectious Bursal Disease Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 60. Infectious Bursal Disease Vaccine Value Chain
Figure 61. Infectious Bursal Disease Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
